Dark circles get blamed on sleep because the eye area is where fatigue becomes visually obvious. The biology is broader. Under-eye darkness can come from pigment, blood, inflammation, skin transparency, fluid, and orbital geometry, with several contributors often occupying the same few centimeters of skin. The useful question is therefore not how dark the circle looks. The useful question is what is creating the contrast.
Dark circles are best understood as a contrast outcome produced by several tissues at once. Melanin, visible vasculature, inflammatory pigment, thin aging skin, edema, and the shape of the tear trough can each increase the difference between the under-eye and the surrounding cheek. Treatment becomes more rational once the dominant contributor is identified.[1]
The color you see is created by skin chromophores such as melanin and hemoglobin, the amount of underlying tissue visible through thin eyelid skin, local inflammation or fluid, and the shadows created by three-dimensional orbital anatomy.[1,3]
Identify the largest contributors to contrast. Pigment, vascular visibility, inflammation, tissue quality, and structure need different interventions, and several can be active at the same time.[1,8]
Reduce the contrast between the lower eyelid and the adjacent cheek by addressing the biology responsible for it. A topical can influence several skin-level contributors. It cannot move bone, reposition fat, or erase a structural shadow.[1,4]
Educational Disclaimer. This article is for informational purposes only and does not constitute medical advice. Persistent eyelid dermatitis, marked swelling, pain, visual symptoms, or a new unexplained change around one eye warrants evaluation by a licensed physician, dermatologist, or ophthalmic clinician.
Executive summary
- Dark circles are usually mixed. A 2026 international consensus still recognizes pigmentary, post-inflammatory, vascular, and shadow-driven presentations, and it recommends identifying the cause before choosing treatment.[1]
- Sleep is an unreliable diagnostic shortcut. In a randomized study of 181 people, one night of total sleep deprivation did not produce a measurable increase in objective periorbital darkness, even though darker under-eyes contributed to how fatigued a face appeared.[2]
- Color contains more than melanin. Spectral imaging has measured both higher melanin and lower hemoglobin oxygen saturation locally in people with dark circles, supporting the idea that several chromophores can contribute to the same visible problem.[3]
- The orbit keeps changing with age. A 2025 MRI study of 236 eyes found age-associated expansion of orbital cavity volume, increased lower orbital fat volume, reduced globe volume, and a more recessed globe position.[4]
- The eye region carries dense aging information. A 2026 imaging study of 2,515 Korean women found that periorbital pigmentation, wrinkles, and morphology tracked chronological age strongly enough to build age-prediction models, although the population limits how broadly the model can be applied.[5]
- Topicals make the most sense when several skin-level pathways are addressed. Recent studies and a 30-year topical review support multi-ingredient approaches, while also showing how limited the field remains by small studies, open-label designs, and mixed causes of darkness.[6,7,8]
- Procedures need the same diagnostic discipline. A 2025 meta-analysis favored lasers and combination approaches across heterogeneous studies, while filler can address shadow in selected patients and carries rare but serious vascular risks.[9,10]
The useful model is contrast
The phrase dark circle makes the problem sound like a patch of brown pigment. That is only one version of it. A dark under-eye can be created by several optical events that land in the same place.
Melanin absorbs light. Blood adds red, blue, and purple optical information depending on vessel depth, oxygenation, skin tone, and surrounding tissue. Thin eyelid skin allows more of that deeper color to influence what you see. Edema changes contour and can create a darker border beside a swollen area. A tear trough creates an actual valley, so overhead or side lighting produces a shadow even when the skin itself is normally pigmented.[1,3]
This gives us a cleaner way to think about the problem. Visible dark-circle severity is partly the contrast between the lower eyelid and the skin beside it. The amount of pigment matters, and the surrounding architecture matters too.
GOA uses the term contrast load in this article as a conceptual framework. It is not a validated medical score. Each contributor can add visible contrast, and the final appearance reflects the combined effect.
The model also explains why a single ingredient can perform well for one person and disappoint another. If vascular visibility is the main contributor, caffeine may be relevant. If inflammatory pigmentation is dominant, pigment-directed and anti-inflammatory strategies matter more. If the problem is mostly a tear-trough shadow, chemistry has reached the edge of what it can do.[1]
Sleep changes the face, but dark circles are a poor sleep meter
Dark circles are socially coded as fatigue. That association is strong enough that people use the eye area to decide whether someone looks tired. It does not follow that darkness under the eye is a reliable measurement of how much sleep that person had.
A randomized 2019 study assigned 181 participants to either one night of total sleep deprivation or a normal night with eight to nine hours in bed. Researchers photographed the faces, used digital analysis for periorbital darkness, and measured skin color in a subset. The sleep-deprived group did not show a significant objective increase in periorbital darkness. At the same time, darker under-eyes were one of the features that made independent observers rate a face as more fatigued.[2]
Dark circles can make a rested man look tired because the eye area is a visual fatigue cue. That does not make the circle a sleep tracker.
GOA Magazine · Periorbital BiologyThis distinction matters. Better sleep is useful for health, recovery, stress regulation, and a long list of reasons that extend beyond skin. It simply should not be treated as a complete explanation for persistent darkness under the eyes.
Color is only part of what you are seeing
Human skin color is shaped by chromophores, especially melanin and hemoglobin, along with scattering through tissue. The under-eye area makes those variables unusually visible because eyelid skin is thin and sits directly over vascular, muscular, and orbital structures.
A spectral imaging study developed a non-contact system that separated relative melanin concentration from hemoglobin oxygen saturation across the face. In participants with dark circles, researchers measured more local melanin and a lower hemoglobin oxygen saturation ratio in the infraorbital area compared with participants without dark circles.[3]
That finding gives the old brown-versus-blue description a more useful biological foundation. Brown can reflect pigment. Blue, purple, or red can reflect vascular contribution through translucent tissue. Many faces contain both.
Inflammation can manufacture new contrast
The 2026 global consensus separates post-inflammatory periorbital hyperpigmentation from constitutional pigmentation and vascular darkness. Atopic dermatitis, allergic contact dermatitis, itching, and repeated rubbing can sustain inflammation, and inflammation can leave pigment behind after the initial irritation settles.[1,11]
This creates a practical failure mode. Someone can spend months trying to fade pigment while continuing to rub irritated eyelids every day. In that situation, the source of new discoloration is still active.
Brown or grey discoloration can reflect constitutional pigmentation or pigment deposited after inflammation. Stretching the lower eyelid does not remove true pigment from view.[1]
Blue, purple, or red coloration can become more visible when vessels sit beneath thin skin. The 2026 consensus specifically places caffeine and vitamin C within the vascular treatment category.[1]
Dermatitis, allergy, itching, and rubbing can add erythema, edema, and post-inflammatory pigment. Treating the trigger matters because repeated irritation can continue creating discoloration.[1,11]
Tear trough depth, lower-lid bags, skin laxity, and the orbital rim can create a shadow that changes with lighting. The skin can be normally pigmented while the area still looks dark.[1,4]
Why the same skin can look darker after 35
The biggest update to the old dark-circle conversation is anatomical. Aging around the eye is not a simple story of losing a little fat and getting thinner skin. Bone, fat, the globe, soft tissue, and surface skin all change, and those changes alter the shape that light falls across.
A 2025 MRI study analyzed 236 eyes from 118 adults across a wide age range. Upper orbital fat volume was relatively stable with age, while lower orbital fat volume increased. Orbital cavity volume increased, globe volume decreased, and the globe became more recessed in the orbit.[4]
Those measurements help explain a common experience after the mid-thirties: the darkness may look stronger even when pigment is not dramatically worse. The topography around the eye has changed. A deeper transition between eyelid and cheek can generate more shadow. Lower-lid fullness can deepen the border beside the tear trough. Skin aging can increase how much of the underlying tissue influences color.
This also changes the treatment conversation. If darkness is being driven largely by contour, adding another brightening ingredient has diminishing value. If the darkness comes mainly from a deep tear trough, asking a serum to erase it is asking chemistry to correct geometry.
The eye area is becoming measurable as an aging region
A January 2026 study adds another important idea. Researchers analyzed periorbital features in 2,515 Korean women aged 20 to 69 using facial imaging, device-based measurements, and computational analysis. They combined pigmentation, wrinkle, and morphological features into age-prediction models, with seven models showing correlations above 0.7 with chronological age.[5]
The interesting part is not the idea that a camera can guess your age. The useful part is that the eye area contains several aging variables that can be quantified together instead of judged as one vague sign of tiredness.
The limitation belongs in the same paragraph. The study population consisted entirely of Korean women, and the research was conducted by scientists affiliated with LG H&H. It does not validate a universal male biological-age score, and it does not prove that dark circles alone reveal systemic aging.[5]
What it does support is a better direction for the field: pigmentation, wrinkles, and morphology can be measured separately, then interpreted together.
Diagnosis is finally catching up with the complexity
The 2026 international consensus is practical here. It recommends the eyelid stretch test and dermoscopy as routine tools for assessing periorbital hyperpigmentation. The stretch test helps separate pigment, vascular contribution, and shadow. Dermoscopy gives clinicians a closer look at pigment and vessels that are difficult to classify by eye alone.[1]
The rules are simple enough to understand without pretending they replace a dermatologist. True pigment tends to remain when the skin is gently stretched. Vascular contribution can become easier to identify as the tissue is stretched. A shadow caused by contour can improve when the lighting or geometry changes.[1]
Imaging can separate what a normal photograph combines
Spectral cameras have already demonstrated the ability to map melanin and hemoglobin-related information separately across the face.[3] More recent cosmetic studies use colorimeters, standardized photography, VISIA imaging, and laser Doppler measurements to track different components of the under-eye area instead of reducing the entire region to one before-and-after photograph.[6]
This is where dark-circle treatment should head. The future is less about finding a universal eye cream and more about quantifying the dominant source of contrast before selecting the intervention.
What topical research actually supports
A 30-year review published in 2025 screened 339 studies and included 22 studies of topical therapies for periorbital dyschromia. The included literature covered caffeine, vitamins, acids, combination serums, peptides, botanical compounds, and other topical approaches. The authors reached the useful conclusion that topicals can help, while future trials need to separate patients by the actual cause of their darkness.[8]
That last point is the important one. A formula can contain legitimate ingredients and still underperform when it is aimed at the wrong layer.
Recent studies are moving toward multi-pathway formulas
A 2024 open-label study followed 40 women aged 35 to 60 using a multi-ingredient eye cream for 12 weeks. Researchers used a Chromameter, VISIA imaging, clinical grading, and laser Doppler measurements. The study reported improvements across dark circles and puffiness, with changes linked to microvascular congestion, melanin, and hemoglobin degradation-related pigmentation.[6]
The caveat matters. Several authors were employed by the product manufacturer, and the study was open-label rather than placebo-controlled.[6] It is useful evidence for the idea that several pathways can be measured at once. It is weaker evidence for declaring one commercial formula universally superior.
A separate 2025 prospective study of 53 subjects tested a formula containing niacinamide, arbutin, tranexamic acid, ubiquinone, and other ingredients for six weeks. Quantitative imaging showed a mean reduction in the study's pigmentation score, but the trial was also open-label and single-arm, with one author affiliated with the company behind the product.[7]
Together, these studies point toward a better formulation philosophy: the under-eye area should be treated as a mixed system. Pigment control, vascular appearance, tissue quality, hydration, and irritation management can all matter. The exact mix should follow the dominant contributors.
Where GOA's Anti-Fatigue Undereye Serum fits
The GOA Anti-Fatigue Undereye Serum contains microencapsulated retinol, liposomal caffeine, niacinamide, sodium ascorbyl phosphate, hyaluronic acid derivatives, peptides, and supporting botanical ingredients.[12] The defensible way to discuss that formula is by mapping ingredients to the layers they can plausibly influence.
| Formula component | Where it fits in the contrast model | What the evidence allows us to say |
|---|---|---|
| Caffeine | Vascular appearance and puffiness | The 2026 consensus specifically recommends topical caffeine for vascular-type periorbital darkness.[1] |
| Niacinamide | Post-inflammatory pigmentation and barrier support | Niacinamide appears in the 2026 consensus options for post-inflammatory periorbital hyperpigmentation.[1] |
| Vitamin C derivative | Pigment and vascular appearance | Vitamin C appears in consensus options for both post-inflammatory and vascular categories.[1] |
| Retinoid system | Skin quality, texture, and visible photoaging | Retinoids have evidence for periorbital wrinkle and texture improvement, but the 2026 dark-circle consensus does not position topical retinoids as a universal treatment for every POH subtype.[13] |
| Peptide system | Skin-quality support | Peptides appear across the periorbital topical literature, although outcomes depend heavily on the exact peptide, concentration, formulation, and study design.[8] |
| Any topical formula | Orbital geometry | A topical cannot reposition lower orbital fat, expand soft tissue volume, or change the bony orbit. Structural shadow requires a structural discussion.[1,4] |
This is the useful product logic. The serum addresses several skin-level pathways in one step, which makes more biological sense than asking a single brightening ingredient to carry the entire job. The boundary is equally important. A deep tear trough, prominent lower-lid bag, or major orbital shadow will remain partly structural even if the skin itself improves.
The procedure evidence is stronger than it used to be, and still messy
A 2025 systematic review and meta-analysis evaluated 33 studies involving 1,320 patients. Across the pooled evidence, laser categories and combination treatments produced the highest proportions of patients achieving good or excellent improvement. Chemical peels, carboxytherapy, and PRP produced lower pooled response rates. Filler and autologous fat showed high improvement in the individual studies that evaluated them, but each of those categories was represented by only one study in the pooled comparison.[9]
That is enough to support combination thinking. It is not enough to crown one universal winner. The studies differed in dark-circle cause, devices, settings, outcome scales, skin types, and treatment combinations. Only a subset could be included in the quantitative meta-analysis.[9]
| Dominant contributor | What current guidance supports | Main limitation |
|---|---|---|
| Constitutional pigment | Topical pigment strategies, chemical peels, and selected laser treatment can be considered.[1] | Pigment depth and skin phototype change both efficacy and risk. |
| Post-inflammatory pigment | Control the inflammatory trigger, then consider ingredients such as vitamin C, niacinamide, azelaic acid, arbutin, thiamidol, or hydroquinone under appropriate guidance.[1] | Ongoing dermatitis or rubbing can continue generating new pigment. |
| Vascular darkness | Caffeine and vitamin C are consensus topical options, and selected vascular laser treatment can be considered clinically.[1] | Color alone does not reliably separate vessels from pigment. |
| Shadow effect | Structural correction can include carefully selected filler, fat repositioning, or surgical approaches depending on anatomy and clinician assessment.[1,9] | Topicals have a hard ceiling when geometry is the main driver. |
| Mixed pattern | Combination therapy is often biologically logical because more than one contributor is active.[9] | Treatment order matters, especially when inflammation is present. |
A necessary correction on tear-trough filler
Filler deserves more nuance than the old idea that it is the obvious fix for every hollow under-eye. The 2026 consensus does place dermal filler within treatment options for the shadow-effect subtype.[1] The risk discussion belongs beside that recommendation.
A 2025 American Academy of Ophthalmology evidence review identified 198 published cases of filler-associated vision loss across included reports. Hyaluronic acid was involved in most of those cases. The majority of reported injection sites were the nose, forehead, glabella, and temple, with periocular sites representing only a small number, so this does not mean tear-trough filler commonly causes blindness. It means vascular occlusion with ocular injury is a rare, documented complication of facial filler that deserves qualified injectors and informed consent.[10]
Structural treatment can be extremely effective in the right anatomy. It should still be treated as a medical procedure rather than a casual extension of skincare.
A practical way to think about your own under-eye area
Look at the under-eye in even frontal light and then in stronger overhead or side light. If the darkness changes dramatically with lighting, structure is contributing. The 2026 consensus describes shadow effects as darkness that can disappear under direct light.[1]
A gentle lower-eyelid stretch can help a clinician distinguish persistent pigment from vascular visibility and shadow. Pigment tends to remain. Vascular structures can become clearer. Shadow can change as the contour changes.[1]
Itching, scaling, recurrent redness, or a habit of rubbing the eyes raises the possibility of dermatitis and post-inflammatory pigmentation. Adding more aggressive actives to irritated eyelid skin can make the situation harder to interpret.[1,11]
Choose a formula that addresses the contributors you can reasonably affect at the surface, including pigment, vascular appearance, hydration, and age-related skin quality. Evaluate change over weeks rather than days, and keep lighting consistent in progress photos.[6,8]
If a deep tear trough or lower-lid bag remains the main source of darkness, a dermatologist, facial plastic surgeon, oculoplastic surgeon, or appropriately trained aesthetic physician can assess whether a procedure makes sense. Structural problems need structural judgment.[1,10]
The new dark-circle rule
The most useful update is simple: stop treating the phrase dark circles as if it identifies one biological problem.
Darkness under the eye is the final visual output of several variables. Pigment can deepen it. Blood can change its hue. Inflammation can create new color and swelling. Aging skin can reveal more of what sits underneath. Orbital anatomy can cast a shadow across skin that is otherwise normal.
The better treatment question is: which layers are creating the contrast, and how much of each layer can actually be changed?
That question protects you from two bad outcomes. The first is spending months treating melanin when the main problem is geometry. The second is jumping to an injectable when inflammation, vascular visibility, or skin quality is contributing more than the hollow itself.
The technology is moving toward better measurement. The clinical guidance is moving toward subtype-based care. The topical literature is moving toward multi-pathway formulas. The science is finally catching up with what the under-eye has been showing all along: one dark circle can contain several different problems in the same place.
Keep Exploring
FAQs
Do dark circles mean I am not sleeping enough?
No single appearance feature can tell you how much sleep you had. In a randomized study of 181 people, one night of total sleep deprivation did not significantly increase objectively measured periorbital darkness. Darker under-eyes did contribute to observers judging a face as more fatigued, which helps explain why the association feels so intuitive.[2]
How can I tell whether my dark circles are pigment or shadow?
Lighting and a gentle stretch test provide useful clues, while dermoscopy gives a clinician more diagnostic information. The 2026 consensus recommends eyelid stretch testing and dermoscopy because true pigment, vascular contribution, and shadow respond differently when the skin or lighting changes.[1]
Can caffeine actually help dark circles?
Caffeine has a defined place rather than a universal one. The 2026 consensus recommends topical caffeine for vascular-type periorbital darkness. It does not recommend caffeine as a structural treatment for tear-trough shadow.[1]
Can retinol remove dark circles?
Retinoids can improve periorbital texture and visible photoaging in clinical studies, which can improve the quality of the tissue contributing to overall appearance. They do not correct every cause of dark circles, and they cannot change orbital anatomy.[13]
When do dark circles need a dermatologist or physician?
Professional evaluation makes sense when darkness is persistent and difficult to classify, when dermatitis or repeated swelling is present, or when you are considering lasers, peels, injectables, or surgery. Pain, visual symptoms, marked swelling, or a new unexplained one-sided change should be evaluated medically rather than treated as a cosmetic issue.
- Passeron T, Desai SR, Abdallah M, Al-Niaimi F, Dlova N, Grimes PE, et al. Global consensus on the management of melanin hyperpigmentation disorders. Journal of the European Academy of Dermatology and Venereology. 2026;40:760-772. https://doi.org/10.1111/jdv.70185
- Holding BC, Sundelin T, Cairns P, Perrett DI, Axelsson J. The effect of sleep deprivation on objective and subjective measures of facial appearance. Journal of Sleep Research. 2019;28:e12860. https://doi.org/10.1111/jsr.12860
- Kikuchi K, Masuda Y, Hirao T. Imaging of hemoglobin oxygen saturation ratio in the face by spectral camera and its application to evaluate dark circles. Skin Research and Technology. 2013. https://pubmed.ncbi.nlm.nih.gov/23750856/
- Lohakitsatian P, Tunlayadechanont P, Tantitham T. Decoding Periorbital Aging: A Multilayered Analysis of Anatomical Changes. Aesthetic Plastic Surgery. 2025;49(3):664-671. https://doi.org/10.1007/s00266-024-04590-1
- Gu KN, Leem S, Kim H, Shin JG, Seo JY, Hwang S, Jeong ET, Kim Y, Kang NG. Periorbital skin index as a biomarker for biological aging and health status. Frontiers in Aging. 2026;7:1715245. https://doi.org/10.3389/fragi.2026.1715245
- Rajabi-Estarabadi A, Hartman CL, Iglesia S, Kononov T, Zahr AS. Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness. Journal of Cosmetic Dermatology. 2024;23:486-495. https://doi.org/10.1111/jocd.16122
- Brady RT, Shah-Desai S. Clinical Efficacy of a Novel Topical Formulation on Periorbital Dark Circles: An Objective Analysis. Journal of Cosmetic Dermatology. 2025;24(7):e70326. https://doi.org/10.1111/jocd.70326
- Woolhiser E, Sobotka M, Burnette C, Gawey L, Dunnick CA. Topical Therapies for Periorbital Dyschromia: A 30-Year Review of the Literature. Dermatologic Surgery. 2025;51(2):157-160. https://doi.org/10.1097/DSS.0000000000004429
- Pour Mohammad A, Zeinali R, Jafary P, Mortaja M, Jafarzadeh A, Goodarzi A. The First Systematic Review and Meta-Analysis of Pharmacological and Nonpharmacological Procedural Treatments of Dark Eye Circles. Dermatologic Therapy. 2025;2025:9155535. https://doi.org/10.1155/dth/9155535
- American Academy of Ophthalmology. Vision-Threatening Complications of Soft Tissue Fillers: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025;132(8):935-944. https://pubmed.ncbi.nlm.nih.gov/40167411/
- Turkiewicz M, Shah A, Yang YW, Mangold A, Shen J. Allergic contact dermatitis of the eyelids: An interdisciplinary review. The Ocular Surface. 2023;28:124-130. https://doi.org/10.1016/j.jtos.2023.03.001
- GOA Skincare. Anti-Fatigue Undereye Serum. Current formulation and ingredient list accessed September 2026. https://goaskincare.com/products/anti-fatigue-undereye-serum
- Kim JE, et al. Improvement in skin wrinkles from the use of photostable retinyl retinoate: a randomized controlled trial. British Journal of Dermatology. 2010. https://pubmed.ncbi.nlm.nih.gov/19849696/
